C-51 Act to amend the food and drug act and to make consequential amendment to other acts with respect to pharmacovigilance and reporting requirements
Legislative Proposal, Bill or Resolution, Regulation
Health care - Health Canada regulatory changes, with respect to Similar Entry Biologics (SEBs)
Industry Canada Patented Medicines Notice of Compliance (PMNOC) Regulations with respect to Patent protection.
Policies or Program
Common Drug Review (CDR), with respect to health economics assessment and recommendations made on new medicines.
Policies or Program, Regulation
Health Canada Regulations, any reimbursement process changes to the Non Insured Health Benefits program with respect to reimbursement of a prescription medicine
Regulation
Patented Medicine Prices Review Board (PMPRB) Regulations.
with regard to prices charged by patentees for patented medicines sold in Canada.